Xinliang Ma

12.8k citations
182 papers · 7.0k indexed · 1 hit paper · h-index 46

Xinliang Ma

179 papers receiving 6.9k citations

Hit Papers

S100a8/a9 Signaling Causes Mitochondrial Dysfunction and ...233201920262021202350100150200

Peers

Xinliang Ma
Comparison fields: 5 of 132
  • Cardiology and Cardiovascular Medicine 2.0k
  • Physiology 1.9k
  • Pathology and Forensic Medicine 1.2k
  • Developmental Neuroscience 209
  • Biochemistry 299
Replace Michael N. Sack with:
Michael N. Sack United States
Fadi N. Salloum United States
Tetsuo Minamino Japan
Wayne Bond Lau United States
Sihem Boudina United States
Tetsuro Ago Japan
Haichang Wang China
Tomomi Ide Japan
Eliot H. Ohlstein United States
Daniel Henrion France
Xinliang Ma relative to Michael N. Sack United States Michael N. Sack's profile →
Citations per field
00.5×1.5×
Michael N. Sack · 1×
Citations per year

Countries citing papers authored by Xinliang Ma

Since Specialization
Citations

This map shows the geographic impact of Xinliang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinliang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinliang Ma more than expected).

Fields of papers citing papers by Xinliang Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinliang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinliang Ma. The network helps show where Xinliang Ma may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xinliang Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xinliang Ma Line = papers co-authored together Xinliang Ma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20245
3 202313
4 202318
5 202146
6 202077
7 201867
8 201736
9 201798
10 2016145
11 201520
12 201465
13 20105
14 201023
15 200338
16 19983
17 199819
18 199736
19 199253
20 199120

About Xinliang Ma

Xinliang Ma is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Physiology, having authored 182 papers that have together received 7.0k indexed citations. Recurring topics across this work include Cardiac Ischemia and Reperfusion (50 papers), Nitric Oxide and Endothelin Effects (39 papers), Adipokines, Inflammation, and Metabolic Diseases (26 papers), Adipose Tissue and Metabolism (18 papers), Cardiovascular Disease and Adiposity (18 papers), Cardiac Fibrosis and Remodeling (12 papers), Signaling Pathways in Disease (11 papers) and Eicosanoids and Hypertension Pharmacology (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.0k citations), Physiology (1.9k citations) and Pathology and Forensic Medicine (1.2k citations). Xinliang Ma has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Wayne Bond Lau, Erhe Gao, Allan M. Lefer, Yajing Wang, Theodore A. Christopher, Bernard L. Lopez, Tianli Yue, Walter J. Koch, Philip S. Tsao and Eliot H. Ohlstein.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026